Login Register Cart 0
Generic placeholder image

Current Diabetes Reviews

Editor-in-Chief

ISSN (Print): 1573-3998
ISSN (Online): 1875-6417

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Mini-Review Article

Glucose Treatment Targets in Pregnancy - A Review of Evidence and Guidelines

Author(s): Abigail R. Byford*, Karen Forbes and Eleanor M. Scott

Volume 19, Issue 2, 2023

Published on: 21 June, 2022

Article ID: e220422203917 Pages: 15

DOI: 10.2174/1573399818666220422083935

open access plus

Abstract

Background: Maternal diabetes mellitus during pregnancy is associated with an increased risk of pregnancy complications for both the mother and the fetus. One of the most prevalent complications is pathological fetal growth, and particularly infants are born large for gestational age (LGA), which leads to problematic deliveries, including the need for caesarean section, instrumental delivery, and further perinatal complications. Glucose monitoring during pregnancy is essential for ensuring appropriate glycaemic control and to reduce these associated risks. The current methods of glucose monitoring include measuring glycosylated haemoglobin (HbA1c), selfmonitoring of capillary blood glucose (SMBG), and more recently, continuous glucose monitoring (CGM). Observational studies and randomised controlled trials (RCTs) have assessed the appropriate glycaemic targets for HbA1c, SMBG, and CGM in relation to pregnancy outcomes.

Objective: In this review, we have identified current international guidelines on glycaemic targets and reviewed the supporting evidence.

Methods: We performed an extensive literature search on glycaemic targets in pregnancies affected by diabetes, and we researched international guidelines from recognised societies.

Results and Conclusion: The majority of studies used to define the glucose targets associated with the best pregnancy outcomes, across all modalities, were in women with type 1 diabetes. There were limited studies on women with type 2 diabetes and gestational diabetes. We, therefore, suggest that further research needs be conducted on glucose targets and clinical outcomes, specifically in these populations where CGM technology offers the greatest potential for monitoring glucose and improving pregnancy outcomes.

Keywords: Glucose, diabetes, pregnancy, glycaemic targets, gestational, type 1 diabetes, type 2 diabetes, pregnancy outcomes.

[1]
Murphy HR, Bell R, Dornhorst A, Forde R, Lewis-Barned N. Pregnancy in diabetes: Challenges and opportunities for improving pregnancy outcomes. Diabet Med 2018; 35(3): 292-9.
[http://dx.doi.org/10.1111/dme.13579] [PMID: 29337383]
[2]
Bell R, Glinianaia SV, Tennant PWG, Bilous RW, Rankin J. Peri-conception hyperglycaemia and nephropathy are associated with risk of congenital anomaly in women with pre-existing diabetes: A population-based cohort study. Diabetologia 2012; 55(4): 936-47.
[http://dx.doi.org/10.1007/s00125-012-2455-y] [PMID: 22314812]
[3]
Tennant PWG, Glinianaia SV, Bilous RW, Rankin J, Bell R. Pre-existing diabetes, maternal glycated haemoglobin, and the risks of fetal and infant death: A population-based study. Diabetologia 2014; 57(2): 285-94.
[http://dx.doi.org/10.1007/s00125-013-3108-5] [PMID: 24292565]
[4]
Miodovnik M, Skillman C, Holroyde JC, Butler JB, Wendel JS, Siddiqi TA. Elevated maternal glycohemoglobin in early pregnancy and spontaneous abortion among insulin-dependent diabetic women. Am J Obstet Gynecol 1985; 153(4): 439-42.
[http://dx.doi.org/10.1016/0002-9378(85)90083-3] [PMID: 4050917]
[5]
Greene MF, Hare JW, Cloherty JP, Benacerraf BR, Soeldner JS. First-trimester hemoglobin A1 and risk for major malformation and spontaneous abortion in diabetic pregnancy. Teratology 1989; 39(3): 225-31.
[http://dx.doi.org/10.1002/tera.1420390303] [PMID: 2727930]
[6]
Negrato CA, Mattar R, Gomes MB. Adverse pregnancy outcomes in women with diabetes. Diabetol Metab Syndr 2012; 4(1): 41.
[http://dx.doi.org/10.1186/1758-5996-4-41] [PMID: 22964143]
[7]
Henriksen T. The macrosomic fetus: A challenge in current obstetrics. Acta Obstet Gynecol Scand 2008; 87(2): 134-45.
[http://dx.doi.org/10.1080/00016340801899289] [PMID: 18231880]
[8]
Jolly MC, Sebire NJ, Harris JP, Regan L, Robinson S. Risk factors for macrosomia and its clinical consequences: A study of 350,311 pregnancies. Eur J Obstet Gynecol Reprod Biol 2003; 111(1): 9-14.
[http://dx.doi.org/10.1016/S0301-2115(03)00154-4] [PMID: 14557004]
[9]
Sparano S, Ahrens W, De Henauw S, et al. Being macrosomic at birth is an independent predictor of overweight in children: Results from the IDEFICS study. Matern Child Health J 2013; 17(8): 1373-81.
[http://dx.doi.org/10.1007/s10995-012-1136-2] [PMID: 22976881]
[10]
Rijpert M, Evers IM, de Vroede MAMJ, de Valk HW, Heijnen CJ, Visser GH. Risk factors for childhood overweight in offspring of type 1 diabetic women with adequate glycemic control during pregnancy: Nationwide follow-up study in the Netherlands. Diabetes Care 2009; 32(11): 2099-104.
[http://dx.doi.org/10.2337/dc09-0652] [PMID: 19651922]
[11]
Manderson JG, Mullan B, Patterson CC, Hadden DR, Traub AI, McCance DR. Cardiovascular and metabolic abnormalities in the offspring of diabetic pregnancy. Diabetologia 2002; 45(7): 991-6.
[http://dx.doi.org/10.1007/s00125-002-0865-y] [PMID: 12136397]
[12]
Deierlein AL, Siega-Riz AM, Chantala K, Herring AH. The association between maternal glucose concentration and child BMI at age 3 years. Diabetes Care 2011; 34(2): 480-4.
[http://dx.doi.org/10.2337/dc10-1766] [PMID: 21216858]
[13]
Hillier TA, Pedula KL, Schmidt MM, Mullen JA, Charles MA, Pettitt DJ. Childhood obesity and metabolic imprinting: The ongoing effects of maternal hyperglycemia. Diabetes Care 2007; 30(9): 2287-92.
[http://dx.doi.org/10.2337/dc06-2361] [PMID: 17519427]
[14]
Evers IM, de Valk HW, Mol BW, ter Braak EW, Visser GH. Macrosomia despite good glycaemic control in type I diabetic pregnancy; results of a nationwide study in The Netherlands. Diabetologia 2002; 45(11): 1484-9.
[http://dx.doi.org/10.1007/s00125-002-0958-7] [PMID: 12436330]
[15]
Law GR, Ellison GTH, Secher AL, et al. Analysis of continuous glucose monitoring in pregnant women with diabetes: Distinct temporal patterns of glucose associated with large-for-gestational-age infants. Diabetes Care 2015; 38(7): 1319-25.
[http://dx.doi.org/10.2337/dc15-0070] [PMID: 25906785]
[16]
Murphy HR, Rayman G, Lewis K, et al. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: Randomised clinical trial. BMJ 2008; 337(sep25 2): a1680.
[http://dx.doi.org/10.1136/bmj.a1680] [PMID: 18818254]
[17]
Rafat D, Ahmad J. HbA1c in pregnancy. Diabetes Metab Syndr 2012; 6(1): 59-64.
[http://dx.doi.org/10.1016/j.dsx.2012.05.010] [PMID: 23014257]
[18]
Middleton P, Crowther CA, Simmonds L. Different intensities of glycaemic control for pregnant women with pre-existing diabetes. Cochrane Database Syst Rev 2016; 2016(5)CD008540
[http://dx.doi.org/10.1002/14651858.CD008540.pub4]
[19]
Weykamp C. HbA1c: A review of analytical and clinical aspects. Ann Lab Med 2013; 33(6): 393-400.
[http://dx.doi.org/10.3343/alm.2013.33.6.393] [PMID: 24205486]
[20]
Nathan DM, Genuth S, Lachin J, et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329(14): 977-86.
[http://dx.doi.org/10.1056/NEJM199309303291401] [PMID: 8366922]
[21]
American diabetes association. 14. Management of diabetes in pregnancy: Standards of medical care in diabetes-2020. Diabetes Care 2020; 43 (Suppl. 1): S183-92.
[http://dx.doi.org/10.2337/dc20-S014] [PMID: 31862757]
[22]
Kilpatrick ES, Rumley AG, Dominiczak MH, Small M. Glycated haemoglobin values: Problems in assessing blood glucose control in diabetes mellitus. BMJ 1994; 309(6960): 983-6.
[http://dx.doi.org/10.1136/bmj.309.6960.983] [PMID: 7950717]
[23]
Jensen DM, Korsholm L, Ovesen P, et al. Peri-conceptional A1C and risk of serious adverse pregnancy outcome in 933 women with type 1 diabetes. Diabetes Care 2009; 32(6): 1046-8.
[http://dx.doi.org/10.2337/dc08-2061] [PMID: 19265024]
[24]
Vääräsmäki MS, Hartikainen A, Anttila M, Pramila S, Koivisto M. Factors predicting peri- and neonatal outcome in diabetic pregnancy. Early Hum Dev 2000; 59(1): 61-70.
[http://dx.doi.org/10.1016/S0378-3782(00)00087-6] [PMID: 10962168]
[25]
Ludvigsson JF, Neovius M, Söderling J, et al. Periconception glycaemic control in women with type 1 diabetes and risk of major birth defects: Population based cohort study in Sweden. BMJ 2018; 362: k2638.
[http://dx.doi.org/10.1136/bmj.k2638] [PMID: 29976596]
[26]
Boulot P, Chabbert-Buffet N, d’Ercole C, et al. French multicentric survey of outcome of pregnancy in women with pregestational diabetes. Diabetes Care 2003; 26(11): 2990-3.
[http://dx.doi.org/10.2337/diacare.26.11.2990] [PMID: 14578228]
[27]
Hauffe F, Fauzan R, Schohe AL, et al. Need for less tight glucose control in early pregnancy after embryogenesis due to high risk of maternal hypoglycaemia in women with pre-existing diabetes can be compensated by good control in late pregnancy. Diabet Med 2020; 37(9): 1490-8.
[http://dx.doi.org/10.1111/dme.14350]
[28]
National Institute for Health and Care Excellence. NCC-WCH Diabetes in pregnancy, NG3 Guidelines. 2015; 1-681.
[29]
Ekbom P, Damm P, Feldt-Rasmussen B, Feldt-Rasmussen U, Jensen DM, Mathiesen ER. Elevated third-trimester haemoglobin A 1c predicts preterm delivery in type 1 diabetes. J Diabetes Complications 2008; 22(5): 297-302.
[http://dx.doi.org/10.1016/j.jdiacomp.2007.03.008] [PMID: 18413167]
[30]
Maresh MJA, Holmes VA, Patterson CC, et al. Glycemic targets in the second and third trimester of pregnancy for women with type 1 diabetes. Diabetes Care 2015; 38(1): 34-42.
[http://dx.doi.org/10.2337/dc14-1755] [PMID: 25368104]
[31]
Damm P, Mersebach H, Råstam J, et al. Poor pregnancy outcome in women with type 1 diabetes is predicted by elevated HbA1c and spikes of high glucose values in the third trimester. J Matern Neonatal Med 2014; 27(2): 149-54.
[http://dx.doi.org/10.3109/14767058.2013.806896] [PMID: 23687948]
[32]
McCance DR, Holmes VA, Maresh MJA, et al. Vitamins C and E for prevention of pre-eclampsia in women with type 1 diabetes (DAPIT): A randomised placebo-controlled trial. Lancet 2010; 376(9737): 259-66.
[http://dx.doi.org/10.1016/S0140-6736(10)60630-7] [PMID: 20580423]
[33]
Mathiesen ER, Kinsley B, Amiel SA, et al. Maternal glycemic control and hypoglycemia in type 1 diabetic pregnancy: A randomized trial of insulin aspart versus human insulin in 322 pregnant women. Diabetes Care 2007; 30(4): 771-6.
[http://dx.doi.org/10.2337/dc06-1887] [PMID: 17392539]
[34]
Lepercq J, Le Ray C, Godefroy C, Pelage L, Dubois-Laforgue D, Timsit J. Determinants of a good perinatal outcome in 588 pregnancies in women with type 1 diabetes. Diabetes Metab 2019; 45(2): 191-6.
[http://dx.doi.org/10.1016/j.diabet.2018.04.007] [PMID: 29776801]
[35]
Abell SK, Boyle JA, de Courten B, et al. Impact of type 2 diabetes, obesity and glycaemic control on pregnancy outcomes. Aust N Z J Obstet Gynaecol 2017; 57(3): 308-14.
[http://dx.doi.org/10.1111/ajo.12521] [PMID: 27593528]
[36]
Murphy HR, Howgate C, O’Keefe J, et al. Characteristics and outcomes of pregnant women with type 1 and type 2 diabetes: National population based 5-year cohort study. Lancet Diabetes Endocrinol 2021; 9(3): 153-64.
[37]
Clinical Management Guidelines for Obstetrician - Gynecologists - pre-existing diabetes. Obstet Gynecol 2018; 132: E229-e248.
[38]
Clinical management guidelines for obstetrician - Gynecologists - GDM. Obstet Gynecol 2018; 131: e49-64.
[39]
Nankervis A, McIntyre H, Moses R, et al. ADIPS consensus guidelines for the testing and diagnosis of gestational diabetes mellitus in Australia. Australas Diabetes Pregnancy Soc 2008; pp. 1-8.
[40]
McIntyre HD, Flack JR. Consensus statement on diabetes control in preparation for pregnancy. Med J Aust 2004; 181(6): 326.
[http://dx.doi.org/10.5694/j.1326-5377.2004.tb06300.x] [PMID: 15377245]
[41]
McElduff A, Cheung NW, McIntyre HD, et al. The Australasian Diabetes in Pregnancy Society consensus guidelines for the management of type 1 and type 2 diabetes in relation to pregnancy. Med J Aust 2005; 183(7): 373-7.
[http://dx.doi.org/10.5694/j.1326-5377.2005.tb07087.x] [PMID: 16201957]
[42]
Feig DS, Berger H, Donovan L, et al. Diabetes and pregnancy. Can J Diabetes 2018; 42 (Suppl. 1): S255-82.
[http://dx.doi.org/10.1016/j.jcjd.2017.10.038] [PMID: 29650105]
[43]
Blumer I, Hadar E, Hadden DR, et al. Diabetes and pregnancy: An endocrine society clinical practice guideline. J Clin Endocrinol Metab 2013; 98(11): 4227-49.
[http://dx.doi.org/10.1210/jc.2013-2465] [PMID: 24194617]
[44]
Joshi T, Oldmeadow C, Attia J, Wynne K. The duration of intrapartum maternal hyperglycaemia predicts neonatal hypoglycaemia in women with pre-existing diabetes. Diabet Med 2017; 34(5): 725-31.
[http://dx.doi.org/10.1111/dme.13337] [PMID: 28199038]
[45]
Nielsen LR, Ekbom P, Damm P, et al. HbA1c levels are significantly lower in early and late pregnancy. Diabetes Care 2004; 27(5): 1200-1.
[http://dx.doi.org/10.2337/diacare.27.5.1200] [PMID: 15111545]
[46]
Yong SL, Ng BK, Mohd Yassin MAJ, Syed Zakaria SZ, Mohamed Ismail NA. Impact of late pregnancy haemoglobin A1c at 29-30 weeks’ gestation on adverse pregnancy outcomes among women with pre-existing diabetes: A retrospective analysis. J Obstet Gynaecol 2018; 38(4): 461-5.
[http://dx.doi.org/10.1080/01443615.2017.1372397] [PMID: 29390907]
[47]
Feig DS, Donovan LE, Zinman B, et al. Metformin in women with type 2 diabetes in pregnancy (MiTy): A multicentre, international, randomised, placebo-controlled trial. Lancet Diabetes Endocrinol 2020; 8(10): 834-44.
[http://dx.doi.org/10.1016/S2213-8587(20)30310-7] [PMID: 32946820]
[48]
Barnes RA, Edghill N, Mackenzie J, et al. Predictors of large and small for gestational age birthweight in offspring of women with gestational diabetes mellitus. Diabet Med 2013; 30(9): 1040-6.
[http://dx.doi.org/10.1111/dme.12207] [PMID: 23551273]
[49]
Mosca A, Paleari R, Dalfrà MG, et al. Reference intervals for hemoglobin A1c in pregnant women: Data from an Italian multicenter study. Clin Chem 2006; 52(6): 1138-43.
[http://dx.doi.org/10.1373/clinchem.2005.064899] [PMID: 16601066]
[50]
Ho YR, Wang P, Lu MC, Tseng ST, Yang CP, Yan YH. Associations of mid-pregnancy HbA1c with gestational diabetes and risk of adverse pregnancy outcomes in high-risk Taiwanese women. PLoS One 2017; 12(5)e0177563
[http://dx.doi.org/10.1371/journal.pone.0177563] [PMID: 28505205]
[51]
Sacks DA, Feig DS, Liu I-LA, Wolde-Tsadik G. Managing type I diabetes in pregnancy: How near normal is necessary? J Perinatol 2006; 26(8): 458-62.
[http://dx.doi.org/10.1038/sj.jp.7211546] [PMID: 16761010]
[52]
Langer O. Glycemic targets for the optimal treatment of GDM. Clin Obstet Gynecol 2013; 56(4): 788-802.
[http://dx.doi.org/10.1097/GRF.0b013e3182a8e07d] [PMID: 24005128]
[53]
Bergenstal RM, Gavin JR. The role of self-monitoring of blood glucose in the care of people with diabetes: Report of a global consensus conference. Am J Med 2005; 118(Suppl 9A0): 1S-6S.
[54]
Bancroft K, Tuffnell DJ, Mason GC, Rogerson LJ, Mansfield M. A randomised controlled pilot study of the management of gestational impaired glucose tolerance. BJOG 2000; 107(8): 959-63.
[http://dx.doi.org/10.1111/j.1471-0528.2000.tb10396.x] [PMID: 10955425]
[55]
Hawkins JS, Casey BM, Lo JY, Moss K, McIntire DD, Leveno KJ. Weekly compared with daily blood glucose monitoring in women with diet-treated gestational diabetes. Obstet Gynecol 2009; 113(6): 1307-12.
[http://dx.doi.org/10.1097/AOG.0b013e3181a45a93] [PMID: 19461427]
[56]
Varner MW. Efficacy of home glucose monitoring in diabetic pregnancy. Obstet Gynecol Surv 1984; 39(7): 427-9.
[http://dx.doi.org/10.1097/00006254-198407000-00006]
[57]
Farrag OAM. Prospective study of 3 metabolic regimens in pregnant diabetics. Aust N Z J Obstet Gynaecol 1987; 27(1): 6-9.
[http://dx.doi.org/10.1111/j.1479-828X.1987.tb00921.x] [PMID: 3304264]
[58]
Demarini S, Mimouni F, Tsang RC, Khoury J, Hertzberg V. Impact of metabolic control of diabetes during pregnancy on neonatal hypocalcemia: A randomized study. Obstet Gynecol 1994; 83(6): 918-22.
[http://dx.doi.org/10.1097/00006250-199406000-00003] [PMID: 8190431]
[59]
Sacks DA, Chen W, Greenspoon JS, Wolde-Tsadik G. Should the same glucose values be targeted for type 1 as for type 2 diabetics in pregnancy? Am J Obstet Gynecol 1997; 177(5): 1113-9.
[http://dx.doi.org/10.1016/S0002-9378(97)70025-5] [PMID: 9396904]
[60]
Rosenn B, Miodovnik M, Combs CA, Khoury J, Siddiqi TA. Glycemic thresholds for spontaneous abortion and congenital malformations in insulin-dependent diabetes mellitus. Obstet Gynecol 1994; 84(4): 515-20.
[PMID: 8090386]
[61]
Combs CA, Gunderson E, Kitzmiller JL, Gavin LA, Main EK. Relationship of fetal macrosomia to maternal postprandial glucose control during pregnancy. Diabetes Care 1992; 15(10): 1251-7.
[http://dx.doi.org/10.2337/diacare.15.10.1251] [PMID: 1425084]
[62]
Herranz L, Pallardo LF, Hillman N, Martin-Vaquero P, Villarroel A, Fernandez A. Maternal third trimester hyperglycaemic excursions predict large-for-gestational-age infants in type 1 diabetic pregnancy. Diabetes Res Clin Pract 2007; 75(1): 42-6.
[http://dx.doi.org/10.1016/j.diabres.2006.05.019] [PMID: 16837097]
[63]
Jovanovic-Peterson L, Peterson CM, Reed GF, et al. Maternal postprandial glucose levels and infant birth weight: The diabetes in early pregnancy study. Am J Obstet Gynecol 1991; 164(1 Pt 1): 103-11.
[http://dx.doi.org/10.1016/0002-9378(91)90637-7] [PMID: 1986596]
[64]
Manderson JG, Patterson CC, Hadden DR, Traub AI, Ennis C, McCance DR. Preprandial versus postprandial blood glucose monitoring in type 1 diabetic pregnancy: A randomized controlled clinical trial. Am J Obstet Gynecol 2003; 189(2): 507-12.
[http://dx.doi.org/10.1067/S0002-9378(03)00497-6] [PMID: 14520226]
[65]
Rowan JA, Gao W, Hague WM, McIntyre HD. Glycemia and its relationship to outcomes in the metformin in gestational diabetes trial. Diabetes Care 2010; 33(1): 9-16.
[http://dx.doi.org/10.2337/dc09-1407] [PMID: 19846793]
[66]
Rowan JA, Hague WM, Gao W, Battin MR, Moore MP. Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med 2008; 358(19): 2003-15.
[http://dx.doi.org/10.1056/NEJMoa0707193] [PMID: 18463376]
[67]
Bonomo M, Cetin I, Pisoni MP, et al. Flexible treatment of gestational diabetes modulated on ultrasound evaluation of intrauterine growth: A controlled randomized clinical trial. Diabetes Metab 2004; 30(3): 237-44.
[http://dx.doi.org/10.1016/S1262-3636(07)70114-3] [PMID: 15223975]
[68]
Martis R, Brown J, Alsweiler J, et al. Different intensities of glycaemic control for women with gestational diabetes mellitus. Cochrane Database Syst Rev 2016; 494CD011624
[http://dx.doi.org/10.1002/14651858.CD011624]
[69]
Snyder J, Morin L, Meltzer S, et al. Gestational diabetes and glycemic control: A randomized clinical trial. Am J Obstet Gynecol 1998; 178(1 Pt 2): S55.
[70]
National institute for health and care excellence. type 1 diabetes in adults: Diagnosis and management, NG17 guidelines. 2015; 1-89. Available from: https://www.nice.org.uk/guidance/ng17
[71]
de Veciana M, Major CA, Morgan MA, et al. Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. N Engl J Med 1995; 333(19): 1237-41.
[http://dx.doi.org/10.1056/NEJM199511093331901] [PMID: 7565999]
[72]
Weisz B, Shrim A, Homko CJ, Schiff E, Epstein GS, Sivan E. One hour versus two hours postprandial glucose measurement in gestational diabetes: A prospective study. J Perinatol 2005; 25(4): 241-4.
[http://dx.doi.org/10.1038/sj.jp.7211243] [PMID: 15605070]
[73]
Advani A. Positioning time in range in diabetes management. Diabetologia 2020; 63(2): 242-52.
[http://dx.doi.org/10.1007/s00125-019-05027-0] [PMID: 31701199]
[74]
Battelino T, Danne T, Bergenstal RM, et al. Clinical targets for continuous glucose monitoring data interpretation: Recommendations from the international consensus on time in range. Diabetes Care 2019; 42(8): 1593-603.
[http://dx.doi.org/10.2337/dci19-0028] [PMID: 31177185]
[75]
Feig DS, Donovan LE, Corcoy R, et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): A multicentre international randomised controlled trial. Lancet 2017; 390(10110): 2347-59.
[http://dx.doi.org/10.1016/S0140-6736(17)32400-5] [PMID: 28923465]
[76]
Kristensen K, Ögge LE, Sengpiel V, et al. Continuous glucose monitoring in pregnant women with type 1 diabetes: An observational cohort study of 186 pregnancies. Diabetologia 2019; 62(7): 1143-53.
[http://dx.doi.org/10.1007/s00125-019-4850-0] [PMID: 30904938]
[77]
Yamamoto JM, Corcoy R, Donovan LE, et al. Maternal glycaemic control and risk of neonatal hypoglycaemia in type 1 diabetes pregnancy: A secondary analysis of the CONCEPTT trial. Diabet Med 2019; 36(8): 1046-53.
[http://dx.doi.org/10.1111/dme.13988] [PMID: 31107983]
[78]
Murphy HR. Continuous glucose monitoring targets in type 1 diabetes pregnancy: Every 5% time in range matters. Diabetologia 2019; 62(7): 1123-8.
[http://dx.doi.org/10.1007/s00125-019-4904-3] [PMID: 31161344]
[79]
Kjölhede K, Berntorp K, Kristensen K, et al. Glycemic, maternal and neonatal outcomes in women with type 1 diabetes using continuous glucose monitoring during pregnancy - pump vs multiple daily injections, a secondary analysis of an observational cohort study. Acta Obstet Gynecol Scand 2021; 100(5): 927-33.
[http://dx.doi.org/10.1111/aogs.14039] [PMID: 33176006]
[80]
Kallas-Koeman MM, Kong JM, Klinke JA, et al. Insulin pump use in pregnancy is associated with lower HbA1c without increasing the rate of severe hypoglycaemia or diabetic ketoacidosis in women with type 1 diabetes. Diabetologia 2014; 57(4): 681-9.
[http://dx.doi.org/10.1007/s00125-014-3163-6] [PMID: 24434960]
[81]
Talaviya PA, Saboo BD, Joshi SR, et al. Pregnancy outcome and glycemic control in women with type 1 diabetes: A retrospective comparison between CSII and MDI treatment. Diabetes Metab Syndr 2013; 7(2): 68-71.
[http://dx.doi.org/10.1016/j.dsx.2013.02.032] [PMID: 23680243]
[82]
Secher AL, Ringholm L, Andersen HU, Damm P, Mathiesen ER. The effect of real-time continuous glucose monitoring in pregnant women with diabetes: A randomized controlled trial. Diabetes Care 2013; 36(7): 1877-83.
[http://dx.doi.org/10.2337/dc12-2360] [PMID: 23349548]
[83]
Raman P, Shepherd E, Dowswell T, Middleton P, Crowther CA. Different methods and settings for glucose monitoring for gestational diabetes during pregnancy. Cochrane Database Syst Rev 2017; 10(10)CD011069
[http://dx.doi.org/10.1002/14651858.CD011069.pub2] [PMID: 29081069]
[84]
Kestilä KK, Ekblad UU, Rönnemaa T. Continuous glucose monitoring versus self-monitoring of blood glucose in the treatment of gestational diabetes mellitus. Diabetes Res Clin Pract 2007; 77(2): 174-9.
[http://dx.doi.org/10.1016/j.diabres.2006.12.012] [PMID: 17234297]
[85]
Wei Q, Sun Z, Yang Y, Yu H, Ding H, Wang S. Effect of a CGMS and SMBG on maternal and neonatal outcomes in gestational diabetes mellitus: A randomized controlled trial. Sci Rep 2016; 6(1): 19920.
[http://dx.doi.org/10.1038/srep19920] [PMID: 26814139]
[86]
Alfadhli E, Osman E, Basri T. Use of a real time continuous glucose monitoring system as an educational tool for patients with gestational diabetes. Diabetol Metab Syndr 2016; 8(1): 48.
[http://dx.doi.org/10.1186/s13098-016-0161-5] [PMID: 27468313]
[87]
Paramasivam SS, Chinna K, Singh AKK, et al. Continuous glucose monitoring results in lower HbA1c in Malaysian women with insulin-treated gestational diabetes: A randomized controlled trial. Diabet Med 2018; 35(8): 1118-29.
[http://dx.doi.org/10.1111/dme.13649] [PMID: 29663517]
[88]
Voormolen DN, DeVries JH, Sanson RME, et al. Continuous glucose monitoring during diabetic pregnancy (GlucoMOMS): A multicentre randomized controlled trial. Diabetes Obes Metab 2018; 20(8): 1894-902.
[http://dx.doi.org/10.1111/dom.13310] [PMID: 29603547]
[89]
Sola-Gazagnes A, Faucher P, Jacqueminet S, et al. Disagreement between capillary blood glucose and flash glucose monitoring sensor can lead to inadequate treatment adjustments during pregnancy. Diabetes Metab 2020; 46(2): 158-63.
[http://dx.doi.org/10.1016/j.diabet.2019.08.001] [PMID: 31415813]
[90]
Law GR, Alnaji A, Alrefaii L, et al. Suboptimal nocturnal glucose control is associated with large for gestational age in treated gestational diabetes mellitus. Diabetes Care 2019; 42(5): 810-5.
[http://dx.doi.org/10.2337/dc18-2212] [PMID: 30765428]
[91]
Scott EM, Feig DS, Murphy HR, et al. Continuous glucose monitoring in pregnancy: Importance of analyzing temporal profiles to understand clinical outcomes. Diabetes Care 2020; 43(6): 1178-84.
[http://dx.doi.org/10.2337/dc19-2527] [PMID: 32209645]
[92]
Tsakiridis I, Giouleka S, Mamopoulos A, et al. Diagnosis and management of gestational diabetes mellitus: An overview of national and international guidelines. Obstet Gynecol Surv 2021; 76(6): 367-81.
[http://dx.doi.org/10.1097/OGX.0000000000000899] [PMID: 34192341]
[93]
National Institute for Health and Care Excellence. 2018 surveillance of diabetes in pregnancy: Management from preconception to the postnatal period (NICE guideline NG3) 2018. Available from: https://www.nice.org.uk/guidance/ng3/resources/2018-surveillance-of-diabetes-in-pregnancy-management-from-preconception-to-the-postnatal-period-nice-guideline-ng3-pdf-6358807780549 Accessed 12 September 2021

Rights & Permissions Print Cite
Article Metrics
13
© 2024 Bentham Science Publishers | Privacy Policy